ARTICLE | Distillery Therapeutics
Otologic
May 9, 2018 3:20 PM UTC
Mouse studies suggest optogenetic therapy using an engineered mutant of the C. noctigama channelrhodopsin Chrimson could help treat age-related hearing loss. The mutant is a version of Chrimson engine...
BCIQ Target Profiles